Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency
Journal of Clinical Lipidology · 2023
DOI: 10.1016/j.jacl.2023.09.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2023. Verfasst von Yu Xia und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology and Genetic Metabolism, Xinhua Hospital, School of Medicine, Shanghai Institute of Pediatric Research, Shanghai…. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type I, Pancreatitis, Hypertriglyceridemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: School of Medicine, Shanghai Jiao Tong University, Shanghai Municipal Population and Family Planning Commission, National Key Research and Development Program of China.
Abstract (Originalsprache)
BACKGROUND: Lipoprotein lipase (LPL) deficiency, the most common familial chylomicronemia syndrome (FCS), is a rare autosomal recessive disease characterized by chylomicronemia and severe hypertriglyceridemia (HTG), with limited clinical and genetic characterization. OBJECTIVE: To describe the manifestations and management of 19 pediatric patients with LPL-FCS. METHODS: LPL-FCS patients from 2014 to 2022 were divided into low-fat (LF), very-low-fat (VLF) and medium-chain-triglyceride (MCT) groups. Their clinical data were evaluated to investigate the effect of different diets. The genotype-phenotype relationship was assessed. Linear regression comparing long-chain triglyceride (LCT) intake and TG levels was analyzed. RESULTS: Nine novel LPL variants were identified in 19 LPL-FCS pediatric patients. At baseline, eruptive xanthomas occurred in 3/19 patients, acute pancreatitis in 2/19, splenomegaly in 6/19 and hepatomegaly in 3/19. The median triglyceride (TG) level (30.3 mmol/L) was markedly increased. The MCT group and VLF group with LCT intakes
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Endocrinology and Genetic Metabolism, Xinhua Hospital, School of Medicine, Shanghai Institute of Pediatric Research, Shanghai Jiao Tong University, 1665 KongJiang Road, Shanghai 200092, China (Dr…
- Department of Endocrinology and Metabolism, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (Dr Chen).
Förderung
- School of Medicine, Shanghai Jiao Tong University
- Shanghai Municipal Population and Family Planning Commission
- National Key Research and Development Program of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Xia, Y., Zheng, W., Du, T., Gong, Z., Liang, L., Wang, R., Yang, Y., Zhang, K., Lu, D., Chen, X., Sun, Y., Sun, Y., Xiao, B., & Qiu, W. (2023). Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2023.09.012
Vancouver
Xia Y, Zheng W, Du T, Gong Z, Liang L, Wang R, et al. Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency. Journal of Clinical Lipidology. 2023. doi:10.1016/j.jacl.2023.09.012
BibTeX
@article{Xia2023,
author = {Xia, Yu and Zheng, Wanqi and Du, Taozi and Gong, Zizhen and Liang, Lili and Wang, Ruifang and Yang, Yi and Zhang, Kaichuang and Lu, Deyun and Chen, Xiaohong and Sun, Yuning and Sun, Yu and Xiao, Bing and Qiu, Wenjuan},
title = {Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency},
journal = {Journal of Clinical Lipidology},
year = {2023},
doi = {10.1016/j.jacl.2023.09.012}
}
EUVIMED